Stethoscope


Health care is on a collision course with patient needs and economic reality. Without significant changes, the scale of the problem will only get worse. Rising costs, mounting evidence of quality problems, and increasing numbers of Americans without insurance are unacceptable and unsustainable, but the future of health care is not predetermined. It is a mistake to extrapolate and attempt to respond to trends within the current structure. Instead, the most pressing task for leaders in the health sector is to create a new and better structure. Effective leaders have the insight to revisit the fundamental purpose of an organization and imagine a different and more effective way to attain it. America can move now to a system based on the right kind of competition that will serve patients far better than either a government-run model or the current U.S. system.

 Doctor and Scrubs
   

 

HEALTH CARE INNOVATION PUBLICATIONS
“How Physicians Can Change the Future of Health Care.” Journal of the American Medical Association, JAMA. 2007;297:1103-1111, March 14, 2007. Co-authored with Michael E. Porter.

“Driving Improvement in Value for Patients.” Online Exclusive, The Cerner Quarterly, vol. 2, no. 3, 2006. http://www.cerner.com/public/CernerQuarterly.asp?id=27750.

Interview: “Michael Porter and Elizabeth Teisberg on Redefining Value in Health Care: An Interview.” Interviewed by Alistair Davidson and Robert M. Randall, Strategy and Leadership, vol. 34, no.6, 2006, pp. 48-50.

“Doctor Know: Information Is The Best Medicine.” The New Republic, July 2006. Co-authored with Michael Porter.

Redefining Health Care: Creating Value Based Competition on Results. Harvard Business School Press. May 2006. Co-authored with Michael E. Porter.

“Redefining Competition in Health Care.” Harvard Business Review, June 2004, pp. 64-77.
Co-authored with Michael E. Porter.

“Fixing Competition in U.S. Health Care.” HBR Research Report, June 2004, Product number 7081. Co-authored with Michael E. Porter.

A Script - Innovation Is the Key.  EIU Healthcare International, Economist Intelligence Unit Limited, 1st Quarter 1997, pp. 79-88. Co-authored with Gregory B. Brown.

“Building on Strength: Upgrading the Medical Device Cluster in Massachusetts.” Governor’s Council on Economic Growth and Technology, prepared for Governor Weld of Massachusetts with the assistance of Yiannis Monovoukas and Scott Wilkin, March 1995. (This work with about 15 CEOs led to the formation of Mass Medical, the state’s medical device industry association.)

“Making Competition in Health Care Work.” Harvard Business Review, July-August 1994, vol. 72, no. 4, pp. 131-141. Co-authored with Michael E. Porter and Gregory B. Brown.

“The Role of Biomedical Research in Health Care Reform.” Science, October 7, 1994. Co-authored with M.W. Kirschner and Elizabeth Marincola.

“Innovation: Medicine's Best Cost-Cutter.” Viewpoints column. The New York Times, February 27, 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

“The Debate on Health Care Reform Continues.” Harvard Business Review, November-December 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

“Finding a Lasting Cure for U.S. Health Care.” Perspectives column. Harvard Business Review, September-October 1994. Co-authored with Michael E. Porter and Gregory B. Brown.

STRATEGY AND REAL OPTIONS PUBLICATIONS

The Portable MBA, Fourth Edition. John Wiley & Sons, Inc., New York, 2003. Co-authored with R.F. Bruner, M.R. Eaker, R.E. Freeman, R.E. Spekman and S. Venkataraman.

“Sustainable Business: Opportunity and Value Creation.” INTERFACES, May-June 2000, 30, no. 3, pp. 1-12. Co-authored with A. Larson and R. Johnson.

Special Issue of INTERFACES on Sustainable Business. May-June 2000. Co-editor with A. Larson.

“Introduction: Strategy, Modeling and Analysis.” INTERFACES, November-December 1999, 29, no. 6, pp. 1-3. Co-authored with S. Bodily.

Special Issue of INTERFACES on Strategy, Analysis and Models. November-December 1999, 29, no. 6. Co-editor with S. Bodily.

The Portable MBA, Third Edition. John Wiley & Sons, Inc., New York, 1998. Co-authored with R.F. Bruner, M.R. Eaker, R.E. Freeman, and R.E. Spekman.
Translated into Japanese (1998), Portuguese (1999), Chinese (1999) and Russian (2000).

“Methods for Evaluating Capital Investment Decisions Under Uncertainty.” Real Options in Capital Investment: New Contributions. Edited by Lenos Trigeorgis. Westport, CT: Praeger Publishing, 1995.

“An Option Valuation Analysis of Investment Choices by a Regulated Firm.” Management Science, April 1994, vol. 40, no. 4, pp. 535-548.

“Capital Investment Strategies Under Uncertain Regulation.” The RAND Journal of Economics, Winter 1993, vol. 24, no. 4, pp. 591-604.

“The Value of Commodity Purchase contracts with Limited Price Risk.” The Energy Journal, 1991, vol. 12, no. 3, pp. 109-135. Co-authored with Thomas J. Teisberg.

“When Choosing R&D Projects, Go with Long Shots.” Research-Technology Management, January-February 1991. Co-authored with A.L. Kolbe and P.A. Morris.

“Investment Cost Recovery and Incentives for Power Plant Construction.” Public Utilities Fortnightly, March 3, 1988, vol. 121, no. 5, pp. 9-14.

“Evaluating the Effects of Time and Risk on Investment Choices: A Comparison of Finance and Decision Analysis.” Electric Power Research Institute Project, 2379-4, January 1987. Co-authored with A.L. Kolbe and P.A. Morris.

OTHER PUBLICATIONS

“Managing Ideas.” Autumn 2003. Batten Briefings. Co-authored with C. Thompson and K. Ramdas.

“Analyzing R&D and Policy Options for the Greenhouse Effect.” The Energy Industries in Transition: 1985-2000, Part I. Edited by J.P. Weyant and D.B. Sheffield, International Association of Energy Economists, 1984. Co-authored with B.R. Judd and L.J. Pollenz.


COURSE DEVELOPMENT MATERIALS

INNOVATION (INCLUDING HEALTH SECTOR INNOVATION)

Sarcos Research Corp 2004, UVA-S-0119

Sarcos Research Corp (TN) 2004, UVA-S-0119TN

Barraquer Clinic 2004, (Columbian eye surgery clinic)

Managing Health Benefits: The Dilemma of Joining the Leapfrog Group (A)
2004, UVA-S-0113

Managing Health Benefits: The Dilemma of Joining the Leapfrog Group (B)
2004, UVA-S-0114

Magnetic Surgery System (A)
December 1999, UVA-OM-0888

Magnetic Surgery System: B, C, D and E
December 1999, UVA-OM-0889, 0890, 0891 and 0892

Managing Innovation at GE Medical Systems (A)
December 1998, UVA-OM-0882

Managing Innovation at GE Medical Systems (B)
1999, UVA-OM-0883

Option Valuation: Insights and Explanations Using a Binomial Approach
July 1999, UVA-OM-0900

Seaflower Associates, Inc.: Valuing Venture Capital with Real Options
January, 1999, UVA-OM-0884

Active Coatings, Inc. (A) - Challenges in Managing Product Development
February 1996, Harvard Business School, no. 9-796-061

Active Coatings, Inc. (B) - Challenges in Managing Product Development
February 1996, Harvard Business School, no. 9-796-062

Note on the FDA Approval Process for Medical Devices
November 1995, Harvard Business School, no. 9-796-063

Zoll Medical Corporation
December 1994, Harvard Business School, no. 9-795-053

Zoll Medical Corporation: B and C
December 1994, Harvard Business School, no. 9-795-054 and no. 9-795-055

Alpha-Beta Technology, Inc., Pioneering Carbohydrate Technology
February, 1994, Harvard Business School, no. 9-794-093

Alpha-Beta Technology, Inc. (B): Trials with Betafectin
December, 1994, Harvard Business School, no. 9-795-045

Diagnosis for the Future: The Genetic Testing Industry in 1993
February 1994, Harvard Business School, no. 9-794-053

IG Laboratories Inc. (A): Pursuing the Future of Genetic Testing
October 1994, Harvard Business School, no. 9-794-054

IG Laboratories, Inc. (B): The Paradox of Growth – 1993-94
February 1996, Harvard Business School, no. 9-796-114

Genzyme Corporation
April 1993, Rev. May 1994, Harvard Business School, no.9-793-120 and TN no. 5-793-122

Biotechnology Strategies in 1992
April 1992, Rev. June 1993, Harvard Business School, no.9-792-082 and TN no. 5-793-036